This clinical trial studies whether a Quality Implementation of Lung Cancer Screening (QUILS™) System state-based initiative (SBI) intervention works to improve the statewide capacity for implementing and sustaining lung cancer screening in Mississippi (MS) and Nevada (NV). The QUILS™ Group is focused on fair and high-quality implementation of lung cancer screening among eligible individuals to reduce lung cancer-related death in underserved communities. They have had success with implementing interventions in Kentucky which has lead to significant increases in lung cancer screening rates and a rapid decline in late-stage lung cancer diagnoses within the state. They hope to offer the opportunity to replicate this work in states which are eager to address suboptimal screening rates, high lung cancer-related death, and significant health equity concerns. The QUILS™ SBI intervention involves translating the success of the initial work in Kentucky to impact lung cancer screening implementation and lung cancer outcomes in MS and NV through close collaboration with state-based partners. The QUILS™ SBI intervention may be an effective way to improve the statewide capacity for implementing and sustaining lung cancer screening in MS and NV.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07682597.
Locations matching your search criteria
United States
Kentucky
Lexington
University of Kentucky/Markey Cancer CenterStatus: Active
Contact: Jennifer Redmond Knight
Phone: 859-509-4123
PRIMARY OBJECTIVES:
I. Increase statewide capacity for implementing and sustaining lung cancer screening (LCS). (State/Community/Policy Level)
II. Improve public awareness, engagement, and support for lung cancer screening (LCS). (State/Community/Policy Level)
III. Enhance coordination and advocacy for positive policy changes that will impact lung cancer screening implementation. (State/Community/Policy Level)
IV. Increase understanding and focus on opportunities to achieve health equity. (State/Community/Policy Level)
V. Implement an initiative focused on enhancing statewide and community-based efforts and policy changes through each state’s lung cancer coalition.
VI. Provide targeted technical assistance and coaching to each state’s lung cancer coalition to increase their capacity to implement lung cancer screening initiatives.
OUTLINE:
Participants implement the QUILS™ SBI intervention over 4 years consisting of the following steps: 1) Hire and establish connections with both groups, work with the Mississippi Lung Cancer Roundtable (MSLCRT) and Nevada Lung Cancer Collaborative (NLCC) during year 1; 2) Participate in annual meetings hosted by MSCLRT and NLCC during years 1-4; 3) Attend State Team Assessment Feedback Sessions during years 2-4; 4) Attend Coalition Assessment Feedback Sessions during years 2-4; 5) Prioritize objectives, identify areas to support, implementation of state-based initiative, and receive coaching/support during years 2 and 3; 6) Receive coaching and technical assistance to implement priority areas during years 1-4; 7) Participate in sustainability planning during year 4.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationUniversity of Kentucky/Markey Cancer Center
Principal InvestigatorJennifer Redmond Knight
